Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 24;22(1):838.
doi: 10.1186/s13063-021-05811-7.

Non-inferiority of low-dose compared to standard high-dose calcium supplementation in pregnancy: study protocol for two randomized, parallel group, non-inferiority trials in India and Tanzania

Pratibha Dwarkanath  1 , Alfa Muhihi  2 , Christopher R Sudfeld  3   4 , Shobha Rani  5 , Christopher P Duggan  3   4   6 , Mary M Sando  2 , Blair J Wylie  7 , Ryan Fernandez  8 , Shabani Kinyogoli  2 , Cristina Munk  3 , Nandita Perumal  3 , John Michael Raj  9 , Nirmala Buggi  5 , Ndeniria Swai  10 , Tinku Thomas  9 , Molin Wang  11   12 , Anura V Kurpad  13 , Honorati Masanja  14 , Andreas B Pembe  15 , Wafaie W Fawzi  16   17   18
Affiliations

Non-inferiority of low-dose compared to standard high-dose calcium supplementation in pregnancy: study protocol for two randomized, parallel group, non-inferiority trials in India and Tanzania

Pratibha Dwarkanath et al. Trials. .

Abstract

Background: Hypertensive disorders of pregnancy are important causes of maternal morbidity and mortality, as well as preterm birth, the leading cause of death for children under 5 years globally. The World Health Organization currently recommends that pregnant women receive high-dose calcium supplementation (1500-2000 mg elemental calcium) for prevention of preeclampsia in populations with low dietary calcium intake. Trials of low-dose calcium supplementation (< 1000 mg elemental calcium/day) during pregnancy have also shown similar reductions in the risk of preeclampsia; however, no trials to date have directly compared low-dose to the standard high-dose calcium supplementation. Our objective is to assess the non-inferiority of low-dose as compared to standard high-dose calcium supplementation in pregnancy.

Methods/design: We will conduct two independent trials in Bangalore, India (n = 11,000 pregnancies), and Dar es Salaam, Tanzania (n = 11,000 pregnancies). The trial designs are individually randomized, parallel group, quadruple-blind, non-inferiority trials of low-dose calcium supplementation (500 mg elemental calcium/day) as compared to standard high-dose calcium supplementation (1500 mg elemental calcium/day) among nulliparous pregnant women. Pregnant women will be enrolled in the trial before 20 weeks of gestation and will receive the randomized calcium regimen from randomization until the time of delivery. The co-primary outcomes are (i) preeclampsia and (ii) preterm birth; we will test non-inferiority of the primary outcomes for low-dose as compared to the standard high-dose supplementation regimen in each trial. The trials' secondary outcomes include gestational hypertension, severe features of preeclampsia, pregnancy-related death, third trimester severe anemia, fetal death, stillbirth, low birthweight, small-for-gestational age birth, and infant death.

Discussion: The trials will provide causal evidence on the non-inferiority of low-dose as compared to the standard high-dose supplementation in India and Tanzania. A single tablet, low-dose calcium supplementation regimen may improve individual-level adherence, reduce programmatic costs, and ultimately expand implementation of routine calcium supplementation in pregnancy in populations with low dietary calcium intake.

Trial registration: ClinicalTrials.gov identifier: NCT03350516 ; registered on 22 November 2018. Clinical Trials Registry-India identifier: CTRI/2018/02/012119 ; registered on 23 February 2018. Tanzania Medicines and Medical Devices Authority Trials Registry identifier: TFDA0018/CTR/0010/5 ; registered on 20 December 2018.

Keywords: Calcium; Dietary supplements; Non-inferiority trial; Pre-eclampsia; Pregnancy; Pregnancy complications; Pregnancy-induced hypertension; Preterm birth.

PubMed Disclaimer

Conflict of interest statement

No competing interests to report for any authors or trial staff member.

Figures

Fig. 1
Fig. 1
Trial flow diagram for the India and Tanzania trials
Fig. 2
Fig. 2
Schedule of enrollment, interventions, and assessments (SPIRIT figure)
See this image and copyright information in PMC

References

    1. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstetrics and gynecology. 2013;122(5):1122-31. - PubMed
    1. Villar K, Say L, Gulmezoglu A, Meraldi M, Lindheimer M, Betran A, et al. Eclampsia and pre-eclampsia: a health problem for 2000 years. Pre-eclampsia. 2003;189:207.
    1. Kassebaum NJ, Barber RM, Bhutta ZA, Dandona L, Gething PW, Hay SI, Kinfu Y, Larson HJ, Liang X, Lim SS, Lopez AD, Lozano R, Mensah GA, Mokdad AH, Naghavi M, Pinho C, Salomon JA, Steiner C, Vos T, Wang H, Abajobir AA, Abate KH, Abbas KM, Abd-Allah F, Abdallat MA, Abdulle AM, Abera SF, Aboyans V, Abubakar I, Abu-Rmeileh NME, Achoki T, Adebiyi AO, Adedeji IA, Adelekan AL, Adou AK, Afanvi KA, Agarwal A, Kiadaliri AA, Ajala ON, Akinyemiju TF, Akseer N, al-Aly Z, Alam K, Alam NKM, Alasfoor D, Aldhahri SF, Aldridge RW, Alhabib S, Ali R, Alkerwi A', Alla F, al-Raddadi R, Alsharif U, Martin EA, Alvis-Guzman N, Amare AT, Amberbir A, Amegah AK, Ammar W, Amrock SM, Andersen HH, Anderson GM, Antoine RM, Antonio CAT, Aregay AF, Ärnlöv J, Arora M, Arsenijevic VSA, Artaman A, Asayesh H, Atique S, Avokpaho EFGA, Awasthi A, Quintanilla BPA, Azzopardi P, Bacha U, Badawi A, Bahit MC, Balakrishnan K, Banerjee A, Barac A, Barker-Collo SL, Bärnighausen T, Basu S, Bayou TA, Bayou YT, Bazargan-Hejazi S, Beardsley J, Wang NH, Bedi, Bekele T, Bell ML, Bennett DA, Bensenor IM, Berhane A, Bernabé E, Betsu BD, Beyene AS, Biadgilign S, Bikbov B, Abdulhak AAB, Biroscak BJ, Biryukov S, Bisanzio D, Bjertness E, Blore JD, Brainin M, Brazinova A, Breitborde NJK, Brugha TS, Butt ZA, Campos-Nonato IR, Campuzano JC, Cárdenas R, Carrero JJ, Carter A, Casey DC, Castañeda-Orjuela CA, Castro RE, Catalá-López F, Cavalleri F, Chang HY, Chang JC, Chavan L, Chibueze CE, Chisumpa VH, Choi JYJ, Chowdhury R, Christopher DJ, Ciobanu LG, Cirillo M, Coates MM, Coggeshall M, Colistro V, Colquhoun SM, Cooper C, Cooper LT, Cortinovis M, Dahiru T, Damasceno A, Danawi H, Dandona R, das Neves J, Leo DD, Dellavalle RP, Deribe K, Deribew A, Des Jarlais DC, Dharmaratne SD, Dicker DJ, Ding EL, Dossou E, Dubey M, Ebel BE, Ellingsen CL, Elyazar I, Endries AY, Ermakov SP, Eshrati B, Esteghamati A, Faraon EJA, Farid TA, Farinha CSS, Faro A, Farvid MS, Farzadfar F, Fereshtehnejad SM, Fernandes JC, Fischer F, Fitchett JRA, Fleming T, Foigt N, Franca EB, Franklin RC, Fraser MS, Friedman J, Fullman N, Fürst T, Futran ND, Gambashidze K, Gamkrelidze A, Gebre T, Gebrehiwot TT, Gebremedhin AT, Gebremedhin M, Gebru AA, Geleijnse JM, Gibney KB, Giref AZ, Giroud M, Gishu MD, Glaser E, Goenka S, Gomez-Dantes H, Gona P, Goodridge A, Gopalani SV, Goto A, Graetz N, Gugnani HC, Guo Y, Gupta R, Gupta R, Gupta V, Hafezi-Nejad N, Hailu AD, Hailu GB, Hamadeh RR, Hamidi S, Hancock J, Handal AJ, Hankey GJ, Harb HL, Harikrishnan S, Harun KM, Havmoeller R, Hoek HW, Horino M, Horita N, Hosgood HD, Hoy DG, Htet AS, Hu G, Huang H, Huang JJ, Huybrechts I, Huynh C, Iannarone M, Iburg KM, Idrisov BT, Iyer VJ, Jacobsen KH, Jahanmehr N, Jakovljevic MB, Javanbakht M, Jayatilleke AU, Jee SH, Jeemon P, Jha V, Jiang G, Jiang Y, Jibat T, Jonas JB, Kabir Z, Kamal R, Kan H, Karch A, Karletsos D, Kasaeian A, Kaul A, Kawakami N, Kayibanda JF, Kazanjan K, Kazi DS, Keiyoro PN, Kemmer L, Kemp AH, Kengne AP, Keren A, Kereselidze M, Kesavachandran CN, Khader YS, Khan AR, Khan EA, Khang YH, Khonelidze I, Khosravi A, Khubchandani J, Kim YJ, Kivipelto M, Knibbs LD, Kokubo Y, Kosen S, Koul PA, Koyanagi A, Krishnaswami S, Defo BK, Bicer BK, Kudom AA, Kulikoff XR, Kulkarni C, Kumar GA, Kutz MJ, Lal DK, Lalloo R, Lam H, Lamadrid-Figueroa H, Lan Q, Larsson A, Laryea DO, Leigh J, Leung R, Li Y, Li Y, Lipshultz SE, Liu PY, Liu S, Liu Y, Lloyd BK, Lotufo PA, Lunevicius R, Ma S, Razek HMAE, Razek MMAE, Majdan M, Majeed A, Malekzadeh R, Mapoma CC, Marcenes W, Margolis DJ, Marquez N, Masiye F, Marzan MB, Mason-Jones AJ, Mazorodze TT, Meaney PA, Mehari A, Mehndiratta MM, Mejia-Rodriguez F, Mekonnen AB, Melaku YA, Memish ZA, Mendoza W, Meretoja A, Meretoja TJ, Mhimbira FA, Miller TR, Mills EJ, Mirarefin M, Misganaw A, Ibrahim NM, Mohammad KA, Mohammadi A, Mohammed S, Mola GLD, Monasta L, de la Cruz Monis J, Hernandez JCM, Montero P, Montico M, Mooney MD, Moore AR, Moradi-Lakeh M, Morawska L, Mori R, Mueller UO, Murthy GVS, Murthy S, Nachega JB, Naheed A, Naldi L, Nand D, Nangia V, Nash D, Neupane S, Newton JN, Ng M, Ngalesoni FN, Nguhiu P, Nguyen G, Nguyen QL, Nisar MI, Nomura M, Norheim OF, Norman RE, Nyakarahuka L, Obermeyer CM, Ogbo FA, Oh IH, Ojelabi FA, Olivares PR, Olusanya BO, Olusanya JO, Opio JN, Oren E, Ota E, Oyekale AS, PA M, Pain A, Papantoniou N, Park EK, Park HY, Caicedo AJP, Patten SB, Paul VK, Pereira DM, Perico N, Pesudovs K, Petzold M, Phillips MR, Pillay JD, Pishgar F, Polinder S, Pope D, Pourmalek F, Qorbani M, Rafay A, Rahimi K, Rahimi-Movaghar V, Rahman M, Rahman MHU, Rahman SU, Rai RK, Ram U, Ranabhat CL, Rangaswamy T, Rao PV, Refaat AH, Remuzzi G, Resnikoff S, Rojas-Rueda D, Ronfani L, Roshandel G, Roy A, Ruhago GM, Sagar R, Saleh MM, Sanabria JR, Sanchez-Niño MD, Santos IS, Santos JV, Sarmiento-Suarez R, Sartorius B, Satpathy M, Savic M, Sawhney M, Saylan MI, Schneider IJC, Schwebel DC, Seedat S, Sepanlou SG, Servan-Mori EE, Setegn T, Shackelford KA, Shaikh MA, Shakh-Nazarova M, Sharma R, She J, Sheikhbahaei S, Shen J, Shibuya K, Shin MJ, Shiri R, Shishani K, Shiue I, Sigfusdottir ID, Silpakit N, Silva DAS, Silveira DGA, Silverberg JI, Simard EP, Sindi S, Singh A, Singh JA, Singh OP, Singh PK, Singh V, Skirbekk V, Sligar A, Sliwa K, Smith JM, Soneji S, Sorensen RJD, Soriano JB, Soshnikov S, Sposato LA, Sreeramareddy CT, Stathopoulou V, Stroumpoulis K, Sturua L, Sunguya BF, Swaminathan S, Sykes BL, Szoeke CEI, Tabarés-Seisdedos R, Tabb KM, Talongwa RT, Tavakkoli M, Taye B, Tedla BA, Tefera WM, Tekle T, Shifa GT, Terkawi AS, Tesfay FH, Tessema GA, Thomson AJ, Thorne-Lyman AL, Tobe-Gai R, Topor-Madry R, Towbin JA, Tran BX, Dimbuene ZT, Tura AK, Tyrovolas S, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Violante FS, Vladimirov SK, Vlassov VV, Vollset SE, Wagner JA, Wang L, Weichenthal S, Weiderpass E, Weintraub RG, Werdecker A, Westerman R, Wijeratne T, Wilkinson JD, Wiysonge CS, Woldeyohannes SM, Wolfe CDA, Wolock T, Won S, Wubshet M, Xiao Q, Xu G, Yadav AK, Yakob B, Yalew AZ, Yano Y, Yebyo HG, Yip P, Yonemoto N, Yoon SJ, Younis MZ, Yu C, Yu S, Zaidi Z, Zaki MES, Zeeb H, Zhao Y, Zhao Y, Zhou M, Zodpey S, Zuhlke LJ, Murray CJL. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1775–1812. doi: 10.1016/S0140-6736(16)31470-2. - DOI - PMC - PubMed
    1. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. European journal of obstetrics, gynecology, and reproductive biology. 2013;170(1):1–7. doi: 10.1016/j.ejogrb.2013.05.005. - DOI - PubMed
    1. Institute for Health Metrics and Evaluation. Making the world a healthier place for mothers: trends and opportunities for action in maternal health.2019.

Publication types

Associated data